EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomics reveals differentially regulated pathways when comparing grade 2 and 4 astrocytomas

Denildo C A Verissimo, Amanda C Camillo-Andrade, Marlon D M Santos, Sergio L Sprengel, Simone C Zanine, Luis A B Borba, Paulo C Carvalho, Juliana de S da G Fischer iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0290087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Denildo C A Verissimo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Structural and Computational Proteomics-Carlos Chagas Institute, Fiocruz Paraná, Curitiba, PR, Brazil. Hauptthemen laut MEDLINE: Brain Neoplasms, Astrocytoma, Glioblastoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Oswaldo Cruz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astrocytic tumors are known for their high progression capacity and high mortality rates; in this regard, proteins correlated to prognosis can aid medical conduct. Although several genetic changes related to progression from grade 2 to grade 4 astrocytoma are already known, mRNA copies do not necessarily correlate with protein abundance and therefore could shadow further comprehension about this tumor’s biology. This motivates us to seek for complementary strategies to study tumor progression at the protein level. Here we compare the proteomic profile of biopsies from patients with grade 2 (diffuse, n = 6) versus grade 4 astrocytomas (glioblastomas, n = 10) using shotgun proteomics. Data analysis performed with PatternLab for proteomics identified 5,206 and 6,004 proteins in the 2- and 4-grade groups, respectively. Our results revealed seventy-four differentially abundant proteins ( p < 0.01); we then shortlist those related to greater malignancy. We also describe molecular pathways distinctly activated in the two groups, such as differences in the organization of the extracellular matrix, decisive both in tumor invasiveness and in signaling for cell division, which, together with marked contrasts in energy metabolism, are determining factors in the speed of growth and dissemination of these neoplasms. The degradation pathways of GABA, enriched in the grade 2 group, is consistent with a favorable prognosis. Other functions such as platelet degranulation, apoptosis, and activation of the MAPK pathway were correlated to grade 4 tumors and, consequently, unfavorable prognoses. Our results provide an important survey of molecular pathways involved in glioma pathogenesis for these histopathological groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsAstrocytomaGlioblastomaHumansProteomicsSignal TransductionProteins

Substanzen

Proteins

Autor:innen und Institutionen

  • Laboratory for Structural and Computational Proteomics-Carlos Chagas Institute, Fiocruz Paraná, Curitiba, PR, Brazil.
  • Clinical Hospital of the Federal University of Paraná, Curitiba, Paraná, Brazil.

ORCID-Profile: Juliana de S da G Fischer

Förderung

  • Fundação Oswaldo Cruz

Zitieren

APA

Verissimo, D. C. A., Camillo-Andrade, A. C., Santos, M. D. M., Sprengel, S. L., Zanine, S. C., Borba, L. A. B., Carvalho, P. C., & da G Fischer, J. S. (2023). Proteomics reveals differentially regulated pathways when comparing grade 2 and 4 astrocytomas. PLOS ONE. https://doi.org/10.1371/journal.pone.0290087

Vancouver

Verissimo DCA, Camillo-Andrade AC, Santos MDM, Sprengel SL, Zanine SC, Borba LAB, et al. Proteomics reveals differentially regulated pathways when comparing grade 2 and 4 astrocytomas. PLOS ONE. 2023. doi:10.1371/journal.pone.0290087

BibTeX
@article{Verissimo2023,
  author = {Verissimo, Denildo C A and Camillo-Andrade, Amanda C and Santos, Marlon D M and Sprengel, Sergio L and Zanine, Simone C and Borba, Luis A B and Carvalho, Paulo C and da G Fischer, Juliana de S},
  title = {Proteomics reveals differentially regulated pathways when comparing grade 2 and 4 astrocytomas},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0290087}
}
Kostenlos starten →